Pricing NDC 0591-1159-30 Acyclovir

Acyclovir

Current Pricing for NDC Package Code 0591-1159-30

The most recent wholesale price for NDC Code 0591-1159-30 is $1.22681 for each billable unit. A package of 1 tube in 1 carton > 30 g in 1 tube of Acyclovir, a human prescription drug labeled by Actavis Pharma, Inc. is priced per "GM" unit. The pricing information is based on the National Average Drug Acquisition Cost (NADAC) and is effective since 08-18-2021.

NADAC pricing data is based on random monthly surveys and reflects the average drug invoice price paid by retail community pharmacies to wholesalers. The data source for this pricing survey was a C/I - Chain or Independent Pharmacy.

Field Name Field Value
Price per Unit $1.22681
Effective Date 08-18-2021 Effective Date
The effective date of the NADAC Per Unit cost.
Pricing Unit GM Pricing Unit
Indicates the pricing unit for the associated NDC (ML, GM or EA).
Pharmacy Type Indicator C/I - Chain or Independent Pharmacy Pharmacy Type Indicator
The source of pharmacy survey data used to calculate the NADAC. 'C/I' indicates data was collected from surveys of Chain/Independent pharmacies. Other pharmacy type indicators are not used at this time.
Explanation Code Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation. Explanation Code
The source of pharmacy survey data used to calculate the NADAC. 'C/I' indicates data was collected from surveys of Chain/Independent pharmacies. Other pharmacy type indicators are not used at this time.
Classification for Rate Setting G - Generic Classification for Rate Setting
Indicates whether the NDC was considered brand (B) or generic (G) for the NADAC rate calculation process. If the NDC was considered brand (B) and approved under an Abbreviated New Drug Application (ANDA), the indicator is shown as (B-ANDA).
As of Date 09-15-2021

The Centers for Medicare and Medicaid Services (CMS) compile the NADAC data based on random monthly surveys on more than 60,000 pharmacies from all 50 states and the District of Columbia. NADAC pricing information is NOT the price paid by end-customers but instead the price paid by pharmacies to drug wholesalers and distributors.

View Package Details

Pricing History for NDC Package Code 0591-1159-30

The following visualiztion reflects the pricing trend of Acyclovir

The NADAC wholesale price of Acyclovir 0591-1159-30 has fluctuated from a low of $0.89720 to a high of $5.39645 per billable unit over a period of 3 years and 5 months. The historical price table below includes all the price changes based on the monthly surveys of retail and chain pharmacies taken by the Centers for Medicare and Medicaid Services (CMS).

Effective Date Price per Unit Pricing Unit Pharmacy Type Indicator Explanation Code Classification Rate Setting
08-18-2021$1.22681GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
07-21-2021$1.99804GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
06-23-2021$1.69650GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
05-19-2021$0.89720GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
04-21-2021$1.64706GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
03-17-2021$0.94150GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
02-17-2021$1.23040GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
01-20-2021$1.04540GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
12-23-2020$1.51406GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
11-18-2020$1.25164GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
10-21-2020$1.28565GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
09-23-2020$1.54047GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
08-19-2020$1.16451GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
07-22-2020$1.27165GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
06-17-2020$1.73009GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
05-20-2020$1.27926GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
04-22-2020$1.35969GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
03-18-2020$1.73815GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
02-19-2020$1.38657GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
01-22-2020$1.50925GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
12-18-2019$1.52045GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
11-20-2019$1.71463GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
10-23-2019$1.82915GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
09-18-2019$1.92972GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
08-21-2019$1.92208GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
07-17-2019$1.94570GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
06-19-2019$1.80847GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
05-22-2019$2.48072GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
04-17-2019$2.96418GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
03-20-2019$2.18385GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
02-20-2019$2.27720GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
01-23-2019$1.91183GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
12-19-2018$3.00411GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
09-05-2018$3.39084GMC/I - Chain or Independent PharmacyCode 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
08-22-2018$3.02464GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
07-18-2018$4.46563GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
06-20-2018$4.41929GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
05-23-2018$4.21928GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
04-18-2018$4.27943GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
03-21-2018$5.39645GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic

The pricing data in this page is based on the National Average Drug Acquisition Cost (NADAC). The NADAC data is compiled by CMS and updated every week. The NADAC dataset is designed to help create a national benchmark reflective of the wholesale prices paid by retails pharmacies to acquire prescription and over-the-counter drugs. The pricing information in this page reflects the reference point that healthcare programs like Medicaid may use to reimburse pharmacies. The pricing data is this page is NOT the price paid by end-customers.

NADAC Pricing Data Last Updated on: 09-15-2021